Ackrell Capital Cannabis Team Biographies – No Direct Controversial Leads
Summary
The document is a standard investment banking team biography for a cannabis investment report, containing only professional backgrounds and contact information. It does not mention any high‑profile po Mike Ackrell founded Ackrell Capital and has a long history in investment banking. Tim Coxon serves as General Counsel with experience in venture capital and corporate litigation. Bryan Castillo has
This document is from the House Oversight Committee Releases.
View Source CollectionTags
Related Documents (6)
Cannabis Investment Report Disclaimer – No Substantive Lead
The document consists solely of legal disclosures, licensing information, and conflict‑of‑interest statements. It contains no names, transactions, dates, or allegations linking any influential actors Purely a disclaimer and licensing notice. Mentions Ackrell Capital LLC and its affiliates only as report preparer. No mention of politicians, cabinet officials, foreign leaders, billionaires, or inte
Directory of Private Cannabis Companies Featured in House Oversight Report
The passage lists several private cannabis producers and their products without mentioning any high‑profile individuals, government agencies, financial transactions, or alleged misconduct. It offers n Level Blends – California cannabis concentrate producer. Lunchbox Alchemy – Oregon cannabis edibles and concentrates maker. LivWell Enlightened Health – Colorado/ Oregon dispensary operator and culti
Cannabis Industry Company Listings in 2017 Investment Report
The passage lists several small cannabis businesses and a research firm with no mention of high‑profile officials, financial misconduct, or controversial actions. It provides no actionable leads, date Identifies Auntie Dolores, a cannabis edibles producer in Oakland, CA. Lists BAS Research, a cannabis oil extraction and manufacturing firm in Berkeley, CA. Mentions Baker Technologies, a CRM platfor
Cannabis Investment Report – Comparison of U.S. Stock Market Listing Requirements (Dec 2017)
The passage only provides generic data on listing standards for Nasdaq, NYSE, and OTC markets. It contains no references to influential actors, financial flows, misconduct, or investigative leads. Most cannabis‑related public companies trade on the OTC due to looser requirements. Nasdaq and NYSE have higher minimum share prices and stricter governance standards. OTC tiers (OTCQX, OTCQB, OTCPink) v
Canadian Public Cannabis Companies Market Overview (Nov 2017)
The passage provides routine financial statistics on publicly traded cannabis firms in Canada with no indication of wrongdoing, influential actors, or novel controversy. It lacks actionable leads, spe As of Nov 30, 2017, 6 firms on TSX, 20 on TSXV, 41 on CSE. Combined enterprise value of Canadian cannabis firms was $210.6 billion. Stock performance boosted by Trudeau's recreational cannabis announ
Directory of Private Cannabis Companies Listed in House Oversight Document
The passage merely lists cannabis businesses and their websites without any allegations, financial flows, or connections to high‑profile officials. It offers no actionable investigative leads, novelty Names and locations of several private cannabis firms (Beboe, BioTrackTHC, Berkeley Patients Group, Brief description of each company's products or services.
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.